Biognosys’ DIA mass spectrometry unbiased proteomics platform.png
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
April 04, 2024 08:11 ET | Biognosys AG
Collaboration brings together Biognosys’ expertise in DIA mass spectrometry and Alamar’s cutting-edge immunoassays to enhance understanding of biomarkers.
Transparency Market Research
Biomarkers Market to Reach USD 125.6 billion by 2031, Projected a CAGR of 10.4%: Report Analysis by Transparency Market Research, Inc.
March 07, 2024 02:31 ET | Transparency Market Research
Wilmington, Delaware, United States, March 07, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global biomarkers market is estimated to flourish at a CAGR of 10.4% from 2023 to...
InsightAce.jpg
Biomarker Discovery Outsourcing Services Market Reach USD 52.82 Billion by 2031 with a CAGR of 20.15% | InsightAce Study States
November 30, 2023 06:09 ET | InsightAce Analytic Pvt. LTd.
Jersey City, NJ, Nov. 30, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market...
TIP_link_300x300.jpg
Neurological Biomarkers Market Worth $14.45 Billion by 2027 – Comprehensive Report by The Insight Partners
October 30, 2023 07:32 ET | The Insight Partners
Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Biomarkers are the molecules that indicate the presence of a disease. The biomarkers of the neurological disorders were not that accessible in earlier...
website-logo (2).png
Biomarkers Market to Hit US$ 215.7 Billion at a CAGR of 14.3% by 2033 : Marketresearch.biz Report
October 30, 2023 05:38 ET | MarketResearch.biz
New York, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The biomarkers market, valued at USD 58.6 billion in 2022, is projected to witness a CAGR of 14.3% from 2023 to 2032. It is expected to reach USD 215.7...
Transparency Market Research
Alzheimer’s Disease Biomarkers Market Predicted to Reach USD 1.7 billion by 2031, Expanding at a 7.5% CAGR Says, Transparency Market Research Inc.
August 14, 2023 07:30 ET | Transparency Market Research
Wilmington, Delaware, United States, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global Alzheimer’s disease biomarkers market is expected to be valued at US$ 953.54...
GME_18x18.jpg
Global Thrombosis and Hemostasis Biomarkers Market Size
June 14, 2023 08:32 ET | Global Market Estimates
Brooklyn, New York, June 14, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Thrombosis and Hemostasis Biomarkers Market is...
new_logo.png
Specimen Validity Testing Market to surpass USD 4.7 billion by 2032, Says Graphical Research Powered by GMI
June 13, 2023 17:00 ET | Graphical Research
Selbyville, Delaware, June 13, 2023 (GLOBE NEWSWIRE) -- Specimen Validity Testing Market size is set to record more than USD 4.7 billion by 2032. The development and innovation of advanced testing...
new_logo.png
Genomics Services Market to surpass USD 12.3 billion by 2032, Says Graphical Research Powered by GMI
June 12, 2023 19:30 ET | Graphical Research
Selbyville, Delaware, June 12, 2023 (GLOBE NEWSWIRE) -- Genomics Services Market size is expected to exceed USD 12.3 billion by 2032. The genomic services industry has experienced significant...
NuProbe BDA Technolo
NuProbe BDA Technology Enables Highly Sensitive Detection of Low-Level Variants for Oncology Research
May 03, 2023 10:00 ET | NuProbe USA Inc
Houston, May 03, 2023 (GLOBE NEWSWIRE) -- NuProbe, a genomics company developing ultrasensitive research assays for detecting and monitoring low-frequency mutations, gene fusions, and copy number...